PhaseBio Pharmaceuticals
2 known investors
PhaseBio Pharmaceuticals develops specialized therapies for cardiovascular disease, which affects a significant portion of the population. The company focuses on innovative drug development to address unmet medical needs in cardiology.
BiotechMedical Devices
Founders & leadership
JS
Joel SussmanExecutive Officer
JK
James K. BarrettDirector
MK
Michael K. GutchDirector
JK
Justin K. KleinDirector
JM
Jonathan MowExecutive Officer, Director
AK
Asish K. XavierDirector
CT
Clay ThorpDirector
GK
Guy K. FishDirector
AC
Ashutosh ChilkotiDirector
RK
Robert K. IngramDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements$26MraisedSep 2018 · 20 investors · Pharmaceuticals
Rule 506(b)$6.6MraisedJan 2017 · 9 investors · Biotechnology
Rule 506(b)$21MraisedJul 2015 · 9 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.